1. Abadie, R. (2010) The Professional Guinea Pig: Big Pharma and the Risky World of Human Subjects. Durham: Duke University Press.
2. Adams, M. and McKevitt, C. (2015) Configuring the patient as clinical research subject in the UK national health service. Anthropology & Medicine, Routledge 22(2): 138–148.
3. Aicardi, C., Del Savio L., Dove, E.S., Lucivero, F., Tempini, N. and Prainsack, B. (2016) Emerging ethical issues regarding digital health data. On the World Medical Association Draft Declaration on Ethical Considerations Regarding Health Databases and Biobanks. Croatian Medical Journal 57(2): 207–213.
4. Aisen, P., Touchon, J., Andrieu, S., Boada, M., Doody, R., Nosheny, R.L., Langbaum, J.B., Schneider, L., Hendrix, S., Wilcock, G., Molinuevo, J.L., Ritchie, C., Ousset, P.-J., Cummings, J., Sperling, R., DeKosky, S.T., Lovestone, S., Hampel, H., Petersen, R., Legrand, V., Egan, M., Randolph, C., Salloway, S., Weiner, M., Vellas, B. and Task Force Members. (2016) Registries and cohorts to accelerate early phase Alzheimer’s trials. A report from the E.U/U.S clinical trials in Alzheimer’s disease task force. Journal of Prevention of Alzheimer’s Disease 3(2): 68–74.
5. Ankeny, R.A. and Leonelli, S. (2015) Valuing data in postgenomic biology: How data donation and curation practices challenge the scientific publication system. In: S.S. Richardson and H. Stevens (eds.) Postgenomics: Perspectives on Biology After the Genome. Durham, N.C.: Duke University Press, pp. 126–149.